# FDA recall D-1779-2019

> **Infusion Options, Inc.** · Class II · drug recall initiated 2019-06-12.

## Product

Fluorouracil 560 MG / 11.2 ML IVP  Fluorouracil 3340 MG QS 92 ML 0.9% NACL  Fluorouracil 3920 MG QS 92 ML 0.9% NACL  Fluorouracil 3760 mg QS 100 ml NS CASS  Fluorouracil 4000 MG QS 92 ml 0.9% NACL  Fluorouracil 3140 MG QS 240 ML NS PUMP  Fluorouracil 2400 MG QS 96 ML 0.9% NACL  Fluorouracil 5000 MG QS 101 ml 0.9% NACL  Fluorouracil 750 MG / 15 ML IVP  Fluorouracil 4500 mg QS 100 ml NS CASS  Fluorouracil 4100 mg QS 100 ml NS CASS  Fluorouracil 690 mg / 13.8 ml IVP  Fluorouracil 2400 MG QS 96 ML NS IV  Fluorouracil 812 MG/16.24 ML IVP  Fluorouracil 4872 MG QS 240 ML NS PUMP  Fluorouracil 4200 mg QS 100 ml NS CASS  Fluorouracil 1110 MG QS 96 ml NS IVPB  Fluorouracil 370 MG/ 50 ML NS  Fluorouracil 620 MG/ 12.4 ML SYRINGE IVP  Fluorouracil 3160 MG QS 92 ML 0.9% NACL  Fluorouracil 1050 mg QS 92 ml NS IVPB  Fluorouracil 370 MG /100 ML NS IVPB  Fluorouracil 4080 MG QS  1000 ML NS IVPB  Fluorouracil 5 MG / 0.1 ML SYRINGE  Fluorouracil 5040 MG QS 101 ml NS CADD  Fluorouracil 4224 MG QS 100 ml NS

## Reason for recall

Lack of Assurance of Sterility

## Distribution

NY only

## Key facts

- **Recall number:** D-1779-2019
- **Recalling firm:** Infusion Options, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-06-12
- **Report date:** 2019-08-21
- **Termination date:** 2025-03-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Brooklyn, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1779-2019

## Citation

> AI Analytics. FDA recall D-1779-2019. Retrieved 2026-07-10 from https://api.ai-analytics.org/recall/D-1779-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*